
The first generation Crystalens accommodating intraocular lens (IOL) (eyeonics) was approved by the FDA in November 2003 and has since undergone two revisions. The first involved modification of the lens optic to a "square" rather than smooth edge in order to reduce the incidence of asymmetric capsular fibrosis, which could cause capsular contraction and IOL tilt